Page 1 | Search Results | Diabetes | American Diabetes Association

1-12 of 12

Sort by

Sort Order Select

Meeting Abstracts

1659-P: Tirzepatide Compared with Semaglutide for the Functions and Mechanisms of Ameliorating Lipid-Metabolism Disorders in Type 2 Diabetic Mice

LIMING CHEN

Diabetes 2024;73(Supplement_1):1659-P

https://doi.org/10.2337/db24-1659-P

Published: 14 June 2024

View articletitled, 1659-P: Tirzepatide Compared with Semaglutide for the Functions and Mechanisms of Ameliorating Lipid-Metabolism Disorders in Type 2 Diabetic Mice

Meeting Abstracts

389-P: ChREBP-ß Aggravates Fructose-Induced Renal Tubular Reabsorption Disorder by Regulating Endoplasmic Reticulum Stress and Mitochondrial Dysfunction

BEI SUN, TING FANG, LIMING CHEN

Diabetes 2024;73(Supplement_1):389-P

https://doi.org/10.2337/db24-389-P

Published: 14 June 2024

View articletitled, 389-P: ChREBP-ß Aggravates Fructose-Induced Renal Tubular Reabsorption Disorder by Regulating Endoplasmic Reticulum Stress and Mitochondrial Dysfunction

Meeting Abstracts

19-PUB: Improved Glycemic Control in People with Type 2 Diabetes (T2D) Initiating or Switching to Insulin Degludec/Insulin Aspart (IDegAsp) in a Real-World Setting in China

LIXIN GUO, LIMING CHEN, FAN ZHAO, XIAO Y. LIU, HONGCHENG DING, KUN WANG, ZHONG XING, VINAY BABU SHANKARAPPA, GAURAV CHAUDHARY

Diabetes 2024;73(Supplement_1):19-PUB

https://doi.org/10.2337/db24-19-PUB

Published: 14 June 2024

View articletitled, 19-PUB: Improved Glycemic Control in People with Type 2 Diabetes (T2D) Initiating or Switching to Insulin Degludec/Insulin Aspart (IDegAsp) in a Real-World Setting in China

Meeting Abstracts

1437-P: Treatment Pattern and Glycemic Control of Adults with T2DM in Northern China

LIMING CHEN, QIUMEI ZHANG, YAQING FAN, XIXI LIU, MINLU ZHANG, GUANGYU WU, MENG WU, QIONG HUANG, YANFANG HAN, LEI KANG, MING LI

Diabetes 2023;72(Supplement_1):1437-P

https://doi.org/10.2337/db23-1437-P

Published: 20 June 2023

View articletitled, 1437-P: Treatment Pattern and Glycemic Control of Adults with T2DM in Northern China

Journal Articles

Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase

Jian-Hui Shi, Jun-Yu Lu, Heng-Yu Chen, Chun-Chun Wei, Xiongfei Xu, Hao Li, Qiufang Bai, Fang-Zhen Xia, Sin Man Lam, Hai Zhang, Ya-Nan Shi, Dongmei Cao, Liming Chen, Guanghou Shui, Xia Yang, Yingli Lu, Yu-Xia Chen, Weiping J. Zhang

Diabetes 2020;69(4):591–602

https://doi.org/10.2337/db19-0388

Published: 23 January 2020

View articletitled, Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase

Includes: Supplementary data

Meeting Abstracts

337-OR: Injection Technique (IT) Training in Subjects Injecting into Lipohypertrophy (LH)—The Tianjin Randomized Controlled Trial (RCT)

LIMING CHEN, QIULING XING, JING LI, JIANXIN ZHOU, YI YUAN, HAIYAN XU, YING WAN, BRIAN K. PFLUG, KENNETH STRAUSS, LAURENCE HIRSCH

Diabetes 2019;68(Supplement_1):337-OR

https://doi.org/10.2337/db19-337-OR

Published: 01 June 2019

View articletitled, 337-OR: Injection Technique (IT) Training in Subjects Injecting into Lipohypertrophy (LH)—The Tianjin Randomized Controlled Trial (RCT)

Meeting Abstracts

1080-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing Patient Satisfaction and Compliance with a Needle-Free Insulin Injector vs. Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

YANGANG WANG, LINONG JI, LIXIN GUO, XINGWU RAN, LIMING CHEN, ZHONGSHU MA, ZILIN SUN, ZHONGYAN SHAN, XIANGJIN XU, GUIXIA WANG

Diabetes 2019;68(Supplement_1):1080-P

https://doi.org/10.2337/db19-1080-P

Published: 01 June 2019

View articletitled, 1080-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing Patient Satisfaction and Compliance with a Needle-Free Insulin Injector vs. Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

Meeting Abstracts

1072-P: Comparison of the Efficacy between a Needle-Free Insulin Injector and Conventional Insulin Pen in Glycemic Control in Insulin-treated Type 2 Diabetic Patients in China

LEILI GAO, LINONG JI, LIXIN GUO, YANGANG WANG, LIMING CHEN, GUIXIA WANG, XINGWU RAN, XIANGJIN XU, ZILIN SUN, ZHONGSHU MA, ZHONGYAN SHAN

Diabetes 2019;68(Supplement_1):1072-P

https://doi.org/10.2337/db19-1072-P

Published: 01 June 2019

View articletitled, 1072-P: Comparison of the Efficacy between a Needle-Free Insulin Injector and Conventional Insulin Pen in Glycemic Control in Insulin-treated Type 2 Diabetic Patients in China

Meeting Abstracts

1068-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

LIMING CHEN, LINONG JI, YANGANG WANG, ZHONGSHU MA, XINGWU RAN, ZILIN SUN, XIANGJIN XU, GUIXIA WANG, LIXIN GUO, ZHONGYAN SHAN

Diabetes 2019;68(Supplement_1):1068-P

https://doi.org/10.2337/db19-1068-P

Published: 01 June 2019

View articletitled, 1068-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

Meeting Abstracts

52-LB: Insulin Cost-Saving Estimate for Injection Technique (IT) Training in Subjects Injecting into Lipohypertrophy (LH)

LIMING CHEN, QIULING XING, JING LI, JIANXIN ZHOU, YUE HOU, NING YUE, YI YUAN

Diabetes 2019;68(Supplement_1):52-LB

https://doi.org/10.2337/db19-52-LB

Published: 01 June 2019

View articletitled, 52-LB: Insulin Cost-Saving Estimate for Injection Technique (IT) Training in Subjects Injecting into Lipohypertrophy (LH)

Journal Articles

NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway

Weili Yang, Junpei Wang, Zhenzhen Chen, Ji Chen, Yuhong Meng, Liming Chen, Yongsheng Chang, Bin Geng, Libo Sun, Lin Dou, Jian Li, Youfei Guan, Qinghua Cui, Jichun Yang

Diabetes 2017;66(7):1819–1832

https://doi.org/10.2337/db16-1172

Published: 14 April 2017

View articletitled, NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway

Includes: Supplementary data

Journal Articles

Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice

Zhenzhen Chen, Liwei Ding, Weili Yang, Junpei Wang, Liming Chen, Yongsheng Chang, Bin Geng, Qinghua Cui, Youfei Guan, Jichun Yang

Diabetes 2017;66(5):1185–1197

https://doi.org/10.2337/db16-0993

Published: 28 February 2017

View articletitled, Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice

Includes: Supplementary data

Update search

NARROW

Format

Journal

Article Type

Topics

Subjects

Issue Section

Date

Availability

1659-P: Tirzepatide Compared with Semaglutide for the Functions and Mechanisms of Ameliorating Lipid-Metabolism Disorders in Type 2 Diabetic Mice

389-P: ChREBP-ß Aggravates Fructose-Induced Renal Tubular Reabsorption Disorder by Regulating Endoplasmic Reticulum Stress and Mitochondrial Dysfunction

19-PUB: Improved Glycemic Control in People with Type 2 Diabetes (T2D) Initiating or Switching to Insulin Degludec/Insulin Aspart (IDegAsp) in a Real-World Setting in China

1437-P: Treatment Pattern and Glycemic Control of Adults with T2DM in Northern China

Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase

337-OR: Injection Technique (IT) Training in Subjects Injecting into Lipohypertrophy (LH)—The Tianjin Randomized Controlled Trial (RCT)

1080-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing Patient Satisfaction and Compliance with a Needle-Free Insulin Injector vs. Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

1072-P: Comparison of the Efficacy between a Needle-Free Insulin Injector and Conventional Insulin Pen in Glycemic Control in Insulin-treated Type 2 Diabetic Patients in China

1068-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

52-LB: Insulin Cost-Saving Estimate for Injection Technique (IT) Training in Subjects Injecting into Lipohypertrophy (LH)

NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway

Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only